Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Unsold Rams May Be Less expensive Than You Suspect - 2Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
- 3Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- 4Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- 5Becoming amazing at Systems administration: Individual and Expert Tips
- 6 Top of the line Lodgings All over The Planet, Which One Do You Concur With
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- The Way to Business: Startup Illustrations Learned
- The Response Uncovered: Disentangling the Secrets of the Universe
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- Vote in favor of the juice that you love for its medical advantages!
- Expert advice for new stargazers: How to begin your amateur astronomy journey
- A mom's viral post is raising the question: Do kids need snacks? Dietitians have answers.
